Skip to content

Public FDA record

Z-0954-2023: CoreLink LLC, FLXFIT 15, 32MM X 8MM, CAGE, REF: AT3208

Recall record Z-0954-2023 for CoreLink LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0954-2023
Company in FDA record
CoreLink LLC
FDA classification date
Jan 12, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Specific lots of FLXfit implants have internal components that may have been manufactured using stainless steel rather than the specified titanium alloy.

Source facts

Action
CoreLink initiated their recall by telephone to the physicians on 10/20/2022. The firm followed with a letter sent by FedEx. The letter explained the problem and the potential risk for health: "Potential Risks to Health: Please be aware that our records indicate your practice may have used one or more of the affected AT3208 devices (as shown in the table above), and that patients implanted with a FLXfit Expandable Interbody Spacer from affected lots should be monitored for: 1. MRI Safety: FLXfit devices, per current labeling, are not approved in the MR environment, and additionally, this labeling does not specify the presence of 17-4 Surgical Grade Stainless Steel. There is a possible risk of patient injury while scanning a patient implanted with FLXfit devices. The additional risk from the presence of steel is believed to be very low as published studies1,2,3, have shown negligible implant heating and no measurable device migration in an MR environment at 3 Tesla with stainless steel implants containing as much as 65% Iron content by weight and 31 times great mass than the affected devices1. 2. Implant Corrosion: There is a remote possibility for implant corrosion over time, which may result in localized pain, swelling, and tenderness, and may weaken the implant. If fusion does not occur, there is an increased potential for implant failure. CoreLink believes this is a remote possibility due in part to the passivation process performed in accordance with ASTM A967 that removes free iron particles on the surface of the affected component and creates a corrosion resistant passive surface layer. 3. Nickel Sensitivity: Patients with nickel sensitivities may experience non-life threatening4,5 allergic reactions to the implant material and implant removal may be necessary to alleviate these effects. We do not anticipate this issue to affect the structural integrity of the implant. The level of Nickel in the component by weight is .9% of the total mass, this is compara
Initiated
2022-10-20
Root cause
Process control
Terminated
2024-08-20
Distribution
US Nationwide distribution.
Recall number
Z-0954-2023
Recall status
Terminated
CDRH record ID
196757
FDA classified
2023-01-12
Recall event number
91109

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗